|
FAQ
 |
| What is the stock symbol for Accentia Biopharmaceuticals and which exchange is the stock listed? |
| |
The stock is listed on the Nasdaq Global Market under the symbol "ABPI". |
Back to top
| Is Accentia stock traded on any of the European exchanges? |
| |
The stock is not currently listed on any foreign exchange. |
Back to top
| When did Accentia Biopharmaceuticals go public? At what price? |
| |
The initial public offering was on October 28, 2005 at $8.00 per share of common stock |
Back to top
| How many shares are outstanding? |
| |
There will be 28,869,196 common shares after this offering. |
Back to top
| Can I purchase share directly from the company? |
| |
You must purchase shares through your own brokerage firm. |
Back to top
| Do you anticipate paying a dividend? |
| |
The Board of Directions can decide to pay dividends at its discretion based on financial condition, results of operation, capital requirements, contractual obligations, and other relevant factors. We do not expect to pay dividends in the first several years following the offering.
|
Back to top
| Does Accentia plan on offering a direct investment program? |
| |
There is currently no direct investment program. |
Back to top
| Who were the underwriters for the Accentia Biopharmaceuticals IPO? |
| |
The initial public offering was underwritten by the following participating firms:
1) Jefferies & Company, Inc.
2) Ferris Baker Watts, Incorporated
3) Stifel Nicklaus & Company
4) GunnAllen Finanacial, inc.
|
Back to top
| Who is the transfer agent? |
| |
The transfer agent is Wachovia Securities. |
Back to top
| Who should I notify to change my mailing address? |
| |
An email to our website will handle this. |
Back to top
| Who do I contact to transfer my shares to another name or a trust? |
| |
Notification in writing to the Secretary of the Corporation, who will then direct the Transfer Agent (Wachovia), as follows:
James A. McNulty
Accentia Biopharmaceuticals, Inc.
324 S. Hyde Park Avenue Suite 350
Tampa FL 33606
jamcnulty@accentia.net |
Back to top
| When is the annual stockholder meeting held? |
| |
The meeting date has not yet been set, but it will be posted on the website once that happens. |
Back to top
| What is Accentia's fiscal year-end? |
| |
The fiscal year ends on September 30th. |
Back to top
| How many employees does Accentia Biopharmaceuticals have? |
| |
There are currently 279 full-time employees. |
Back to top
| Can I get an investor's packet or a copy of Accentia's prospectus? |
| |
Please refer to the Investor Relation contact form. |
Back to top
| I am a shareholder in Biovest International, which Accentia owns 81%. Are my Biovest shares converted to Accentia stock? |
| |
Biovest shares are distinct and do convert to Accentia shares. |
Back to top
|
|
